Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 2Thoracic 1Myeloid 1

Conditions

Venous Thromboembolism 1Treatment of Venous Thromboembolism in Cancer Patients 1Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Hemorrhage 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2384Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1831Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1016Vincristine 964Cetuximab 945Trastuzumab 944Prednisone 941Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
N(4)-oleylcytosine arabinoside × Clear all
NCT05498428 2026-05-08

PALOMA-2

Janssen Research & Development, LLC

Phase 2 Recruiting
520 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05198960 2026-03-20

AVAJAK

University Hospital, Brest

Phase 3 Recruiting
1,308 enrolled
Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT04979780 2024-10-31

OSCAR-US

Bayer

Completed
3,708 enrolled
Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡